Downloadable Slides

Share

Program Content

Activities

  • Evidence for SERDs Tx
    The Expanding Evidence Base for Oral SERDs and Other ER-Targeting Agents
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

  • Future for SERD Tx
    Possibilities for the Future of SERD Therapy for HR+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

  • SERD for ET Resistance
    Steps Toward Precision Oncology: Role of SERD in Attacking Endocrine Resistance in HR+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

Faculty

cover img faculity

Aditya Bardia, MD, MPH, FASCO

Professor of Medicine
Geffen School of Medicine at UCLA
Director, Breast Oncology Program
Assistant Chief (Translational Research)
Division of Medical Oncology
Director of Translational Research Integration
UCLA Health Jonsson Comprehensive Cancer Center
Los Angeles, California

cover img faculity

Virginia Kaklamani, MD, DSc

Professor of Medicine
Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment
A.B. Alexander Distinguished Chair in Oncology
Leader
Breast Oncology Program
UT Health San Antonio
MD Anderson Cancer Center
San Antonio, Texas

cover img faculity

Sarah Sammons, MD

Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Lilly.

AstraZeneca

Lilly